<VariationArchive VariationID="372387" VariationName="NM_001099857.5(IKBKG):c.1167dup (p.Glu390fs)" VariationType="Duplication" Accession="VCV000372387" Version="13" RecordType="classified" NumberOfSubmissions="7" NumberOfSubmitters="6" DateLastUpdated="2024-07-29" DateCreated="2017-01-09" MostRecentSubmission="2024-07-29">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="360602" VariationID="372387">
      <GeneList>
        <Gene Symbol="IKBKG" FullName="inhibitor of nuclear factor kappa B kinase regulatory subunit gamma" GeneID="8517" HGNC_ID="HGNC:5961" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154541238" stop="154565046" display_start="154541238" display_stop="154565046" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153770458" stop="153793260" display_start="153770458" display_stop="153793260" Strand="+" />
          </Location>
          <OMIM>300248</OMIM>
          <Haploinsufficiency last_evaluated="2020-11-10" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=IKBKG">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-11-10" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=IKBKG">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_001099857.5(IKBKG):c.1167dup (p.Glu390fs)</Name>
      <CanonicalSPDI>NC_000023.11:154564361:CCCCCCC:CCCCCCCC</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>Xq28</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154564361" stop="154564362" display_start="154564361" display_stop="154564362" variantLength="1" positionVCF="154564361" referenceAlleleVCF="G" alternateAlleleVCF="GC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153792576" stop="153792577" display_start="153792576" display_stop="153792577" variantLength="1" positionVCF="153792576" referenceAlleleVCF="G" alternateAlleleVCF="GC" />
      </Location>
      <OtherNameList>
        <Name>p.(E390Rfs*5)</Name>
      </OtherNameList>
      <ProteinChange>E390fs</ProteinChange>
      <ProteinChange>E389fs</ProteinChange>
      <ProteinChange>E291fs</ProteinChange>
      <ProteinChange>E458fs</ProteinChange>
      <ProteinChange>E267fs</ProteinChange>
      <ProteinChange>E338fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003639.3" sequenceAccession="NM_003639" sequenceVersion="3" change="c.1167dupC">
            <Expression>NM_003639.3:c.1167dupC</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.153792583dup" Assembly="GRCh37">
            <Expression>NC_000023.10:g.153792583dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.154564368dup" Assembly="GRCh38">
            <Expression>NC_000023.11:g.154564368dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009896.1" sequenceAccession="NG_009896" sequenceVersion="1" change="g.27125dup">
            <Expression>NG_009896.1:g.27125dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001099856.6" sequenceAccession="NM_001099856" sequenceVersion="6" change="c.1371dup">
            <Expression>NM_001099856.6:c.1371dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001093326.2" sequenceAccession="NP_001093326" sequenceVersion="2" change="p.Glu458fs">
            <Expression>NP_001093326.2:p.Glu458fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001099857.5" sequenceAccession="NM_001099857" sequenceVersion="5" change="c.1167dup" MANESelect="true">
            <Expression>NM_001099857.5:c.1167dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001093327.1" sequenceAccession="NP_001093327" sequenceVersion="1" change="p.Glu390fs">
            <Expression>NP_001093327.1:p.Glu390fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001145255.4" sequenceAccession="NM_001145255" sequenceVersion="4" change="c.870dup">
            <Expression>NM_001145255.4:c.870dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001138727.1" sequenceAccession="NP_001138727" sequenceVersion="1" change="p.Glu291fs">
            <Expression>NP_001138727.1:p.Glu291fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001321396.3" sequenceAccession="NM_001321396" sequenceVersion="3" change="c.1167dup">
            <Expression>NM_001321396.3:c.1167dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001308325.1" sequenceAccession="NP_001308325" sequenceVersion="1" change="p.Glu390fs">
            <Expression>NP_001308325.1:p.Glu390fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001321397.3" sequenceAccession="NM_001321397" sequenceVersion="3" change="c.1164dup">
            <Expression>NM_001321397.3:c.1164dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001308326.1" sequenceAccession="NP_001308326" sequenceVersion="1" change="p.Glu389fs">
            <Expression>NP_001308326.1:p.Glu389fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001377312.1" sequenceAccession="NM_001377312" sequenceVersion="1" change="c.1167dup">
            <Expression>NM_001377312.1:c.1167dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001364241.1" sequenceAccession="NP_001364241" sequenceVersion="1" change="p.Glu390fs">
            <Expression>NP_001364241.1:p.Glu390fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001377313.1" sequenceAccession="NM_001377313" sequenceVersion="1" change="c.1164dup">
            <Expression>NM_001377313.1:c.1164dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001364242.1" sequenceAccession="NP_001364242" sequenceVersion="1" change="p.Glu389fs">
            <Expression>NP_001364242.1:p.Glu389fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001377314.1" sequenceAccession="NM_001377314" sequenceVersion="1" change="c.1011dup">
            <Expression>NM_001377314.1:c.1011dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001364243.1" sequenceAccession="NP_001364243" sequenceVersion="1" change="p.Glu338fs">
            <Expression>NP_001364243.1:p.Glu338fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001377315.1" sequenceAccession="NM_001377315" sequenceVersion="1" change="c.798dup">
            <Expression>NM_001377315.1:c.798dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001364244.1" sequenceAccession="NP_001364244" sequenceVersion="1" change="p.Glu267fs">
            <Expression>NP_001364244.1:p.Glu267fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003639.4" sequenceAccession="NM_003639" sequenceVersion="4" change="c.1167dup">
            <Expression>NM_003639.4:c.1167dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_003630.1" sequenceAccession="NP_003630" sequenceVersion="1" change="p.Glu390fs">
            <Expression>NP_003630.1:p.Glu390fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_165197.1" sequenceAccession="NR_165197" sequenceVersion="1" change="n.1036dup">
            <Expression>NR_165197.1:n.1036dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_70" sequenceAccession="LRG_70">
            <Expression>LRG_70:g.27125dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_70t1" sequenceAccession="LRG_70t1">
            <Expression>LRG_70t1:c.1167dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001099856.6" sequenceAccession="NM_001099856" sequenceVersion="6" change="c.1371_1372insC">
            <Expression>NM_001099856.6:c.1371_1372insC</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA10566455" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="300248.0008" DB="OMIM" />
        <XRef Type="rs" ID="782178147" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001099857.5(IKBKG):c.1167dup (p.Glu390fs) AND Ectodermal dysplasia and immunodeficiency 1" Accession="RCV000012209" Version="21">
        <ClassifiedConditionList TraitSetID="3126">
          <ClassifiedCondition DB="MedGen" ID="C1846008">Ectodermal dysplasia and immunodeficiency 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2001-09-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001099857.5(IKBKG):c.1167dup (p.Glu390fs) AND not provided" Accession="RCV000413717" Version="4">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-12-14" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001099857.5(IKBKG):c.1167dup (p.Glu390fs) AND Incontinentia pigmenti syndrome" Accession="RCV001172473" Version="8">
        <ClassifiedConditionList TraitSetID="3124">
          <ClassifiedCondition DB="MedGen" ID="C0021171">Incontinentia pigmenti syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description SubmissionCount="3">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001099857.5(IKBKG):c.1167dup (p.Glu390fs) AND multiple conditions" Accession="RCV002506000" Version="1">
        <ClassifiedConditionList TraitSetID="56588">
          <ClassifiedCondition DB="MedGen" ID="C1846008">Ectodermal dysplasia and immunodeficiency 1</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1970879">Immunodeficiency 33</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0021171">Incontinentia pigmenti syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-10-27" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001099857.5(IKBKG):c.1167dup (p.Glu390fs) AND Immunodeficiency 33" Accession="RCV003992285" Version="1">
        <ClassifiedConditionList TraitSetID="6526">
          <ClassifiedCondition DB="MedGen" ID="C1970879">Immunodeficiency 33</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2023-05-10" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-12-14" NumberOfSubmissions="7" NumberOfSubmitters="6" DateCreated="2017-01-09" MostRecentSubmission="2024-07-29">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11047757</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">11179023</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">11484156</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">18222329</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">8169255</ID>
        </Citation>
        <Citation Type="review" Abbrev="GeneReviews">
          <ID Source="PubMed">20301645</ID>
          <ID Source="BookShelf">NBK1472</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="3124" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2304" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Incontinentia pigmenti syndrome</ElementValue>
                <XRef ID="Incontinentia+pigmenti/3798" DB="Genetic Alliance" />
                <XRef ID="367520004" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Incontinentia pigmenti, familial male-lethal type</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Bloch-Sulzberger syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Incontinentia pigmenti type 2 (formerly)</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">IP2 (formerly)</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">INCONTINENTIA PIGMENTI, TYPE II</ElementValue>
                <XRef Type="MIM" ID="308300" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">IP</ElementValue>
                <XRef Type="MIM" ID="308300" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">IP2</ElementValue>
                <XRef Type="MIM" ID="308300" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Incontinentia pigmenti (IP) is a disorder that affects the skin, hair, teeth, nails, eyes, and central nervous system; it occurs primarily in females and on occasion in males. Characteristic skin lesions evolve through four stages: I. Blistering (birth to age ~4 months). II. Wart-like rash (for several months). III. Swirling macular hyperpigmentation (age ~6 months into adulthood). IV. Linear hypopigmentation. Alopecia, hypodontia, abnormal tooth shape, and dystrophic nails are observed. Neovascularization of the retina, present in some individuals, predisposes to retinal detachment. Neurologic findings including seizures, intellectual disability, and developmental delays are occasionally seen.</Attribute>
                <XRef ID="NBK1472" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6778" />
                <XRef ID="6778" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301645</ID>
                <ID Source="BookShelf">NBK1472</ID>
              </Citation>
              <XRef ID="464" DB="Orphanet" />
              <XRef ID="C0021171" DB="MedGen" />
              <XRef ID="MONDO:0010631" DB="MONDO" />
              <XRef Type="MIM" ID="308300" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="3126" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="1582" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Hyper-IgM immunodeficiency, X-linked, with hypohidrotic ectodermal dysplasia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">ECTODERMAL DYSPLASIA AND IMMUNE DEFICIENCY 1</ElementValue>
                <XRef Type="Allelic variant" ID="300248.0013" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Ectodermal dysplasia and immunodeficiency 1</ElementValue>
                <XRef ID="MONDO:0020740" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Ectodermal dysplasia, anhidrotic, with immunodeficiency, osteopetrosis, and lymphedema</ElementValue>
                <XRef ID="Ectodermal+dysplasia%2C+anhidrotic%2C+with+immunodeficiency%2C+osteopetrosis%2C+and+lymphedema/8290" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">ECTODERMAL DYSPLASIA, ANHIDROTIC, WITH IMMUNE DEFICIENCY</ElementValue>
                <XRef Type="MIM" ID="300291" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">EDAID1</ElementValue>
                <XRef Type="MIM" ID="300291" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">HEDID</ElementValue>
                <XRef Type="MIM" ID="300291" DB="OMIM" />
              </Symbol>
              <XRef ID="238468" DB="Orphanet" />
              <XRef ID="98813" DB="Orphanet" />
              <XRef ID="C1846008" DB="MedGen" />
              <XRef ID="MONDO:0020740" DB="MONDO" />
              <XRef Type="MIM" ID="300291" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="6526" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="569" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Immunodeficiency 33</ElementValue>
                <XRef ID="MONDO:0010386" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Immunodeficiency without anhidrotic ectodermal dysplasia</ElementValue>
                <XRef ID="Immunodeficiency+without+anhidrotic+ectodermal+dysplasia/3781" DB="Genetic Alliance" />
                <XRef ID="MONDO:0010368" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">X-linked mendelian susceptibility to mycobacterial diseases due to IKBKG deficiency</ElementValue>
                <XRef ID="319612" DB="Orphanet" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">IPD2</ElementValue>
                <XRef Type="MIM" ID="300636" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">IMD33</ElementValue>
                <XRef Type="MIM" ID="300636" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="12915" />
                <XRef ID="12915" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9917" />
                <XRef ID="9917" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="319605" DB="Orphanet" />
              <XRef ID="319612" DB="Orphanet" />
              <XRef ID="C1970879" DB="MedGen" />
              <XRef ID="MONDO:0010386" DB="MONDO" />
              <XRef Type="MIM" ID="300636" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="56588" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1582" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Hyper-IgM immunodeficiency, X-linked, with hypohidrotic ectodermal dysplasia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">ECTODERMAL DYSPLASIA AND IMMUNE DEFICIENCY 1</ElementValue>
                <XRef Type="Allelic variant" ID="300248.0013" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Ectodermal dysplasia and immunodeficiency 1</ElementValue>
                <XRef ID="MONDO:0020740" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Ectodermal dysplasia, anhidrotic, with immunodeficiency, osteopetrosis, and lymphedema</ElementValue>
                <XRef ID="Ectodermal+dysplasia%2C+anhidrotic%2C+with+immunodeficiency%2C+osteopetrosis%2C+and+lymphedema/8290" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">ECTODERMAL DYSPLASIA, ANHIDROTIC, WITH IMMUNE DEFICIENCY</ElementValue>
                <XRef Type="MIM" ID="300291" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">EDAID1</ElementValue>
                <XRef Type="MIM" ID="300291" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">HEDID</ElementValue>
                <XRef Type="MIM" ID="300291" DB="OMIM" />
              </Symbol>
              <XRef ID="238468" DB="Orphanet" />
              <XRef ID="98813" DB="Orphanet" />
              <XRef ID="C1846008" DB="MedGen" />
              <XRef ID="MONDO:0020740" DB="MONDO" />
              <XRef Type="MIM" ID="300291" DB="OMIM" />
            </Trait>
            <Trait ID="2304" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Incontinentia pigmenti syndrome</ElementValue>
                <XRef ID="Incontinentia+pigmenti/3798" DB="Genetic Alliance" />
                <XRef ID="367520004" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Incontinentia pigmenti, familial male-lethal type</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Bloch-Sulzberger syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Incontinentia pigmenti type 2 (formerly)</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">IP2 (formerly)</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">INCONTINENTIA PIGMENTI, TYPE II</ElementValue>
                <XRef Type="MIM" ID="308300" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">IP</ElementValue>
                <XRef Type="MIM" ID="308300" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">IP2</ElementValue>
                <XRef Type="MIM" ID="308300" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Incontinentia pigmenti (IP) is a disorder that affects the skin, hair, teeth, nails, eyes, and central nervous system; it occurs primarily in females and on occasion in males. Characteristic skin lesions evolve through four stages: I. Blistering (birth to age ~4 months). II. Wart-like rash (for several months). III. Swirling macular hyperpigmentation (age ~6 months into adulthood). IV. Linear hypopigmentation. Alopecia, hypodontia, abnormal tooth shape, and dystrophic nails are observed. Neovascularization of the retina, present in some individuals, predisposes to retinal detachment. Neurologic findings including seizures, intellectual disability, and developmental delays are occasionally seen.</Attribute>
                <XRef ID="NBK1472" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6778" />
                <XRef ID="6778" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301645</ID>
                <ID Source="BookShelf">NBK1472</ID>
              </Citation>
              <XRef ID="464" DB="Orphanet" />
              <XRef ID="C0021171" DB="MedGen" />
              <XRef ID="MONDO:0010631" DB="MONDO" />
              <XRef Type="MIM" ID="308300" DB="OMIM" />
            </Trait>
            <Trait ID="569" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Immunodeficiency 33</ElementValue>
                <XRef ID="MONDO:0010386" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Immunodeficiency without anhidrotic ectodermal dysplasia</ElementValue>
                <XRef ID="Immunodeficiency+without+anhidrotic+ectodermal+dysplasia/3781" DB="Genetic Alliance" />
                <XRef ID="MONDO:0010368" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">X-linked mendelian susceptibility to mycobacterial diseases due to IKBKG deficiency</ElementValue>
                <XRef ID="319612" DB="Orphanet" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">IPD2</ElementValue>
                <XRef Type="MIM" ID="300636" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">IMD33</ElementValue>
                <XRef Type="MIM" ID="300636" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="12915" />
                <XRef ID="12915" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9917" />
                <XRef ID="9917" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="319605" DB="Orphanet" />
              <XRef ID="319612" DB="Orphanet" />
              <XRef ID="C1970879" DB="MedGen" />
              <XRef ID="MONDO:0010386" DB="MONDO" />
              <XRef Type="MIM" ID="300636" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="958041" SubmissionDate="2022-12-21" DateLastUpdated="2022-12-24" DateCreated="2017-01-09">
        <ClinVarSubmissionID localKey="GDXSV:253541" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV000490564" DateUpdated="2022-12-24" DateCreated="2017-01-09" Type="SCV" Version="4" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-12-14">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Published functional studies demonstrate a damaging effect on protein function (Ohnishi et al., 2017; Kawai et al., 2012); Frameshift variant in the C-terminus predicted to result in protein truncation, as the last 30 amino acids are lost and replaced with 4 incorrect amino acids; truncated region removes a portion of the zinc finger domain (HGMD); Not observed in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 22517901, 18350553, 11484156, 18347290, 30982207, 31713830, 32035679, 34061330, 11047757, 27577878, 18222329, 11179023, 28702714)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="IKBKG" />
          </GeneList>
          <VariantType>Duplication</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:26711</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_003639.3:c.1167dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_152_20221221054204</SubmissionName>
          <SubmissionName>GeneDX_Clinvar_Submission_55_20210929044204</SubmissionName>
          <SubmissionName>SUB5098196</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="32443" SubmissionDate="2022-05-27" DateLastUpdated="2024-07-29" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="300248.0008_ECTODERMAL DYSPLASIA AND IMMUNODEFICIENCY 1" title="IKBKG, 1-BP DUP, 1167C_ECTODERMAL DYSPLASIA AND IMMUNODEFICIENCY 1" />
        <ClinVarAccession Accession="SCV000032443" DateUpdated="2024-07-29" DateCreated="2013-04-04" Type="SCV" Version="10" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2001-09-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 2 brothers (family 4) with lethal hypohidrotic ectodermal dysplasia with immune deficiency-1 (EDAID1; 300291), Zonana et al. (2000) identified a hemizygous 1-bp duplication (c.1167_1168dupC) in exon 10 of the IKBKG gene, predicted to result in a frameshift, the addition of novel amino acids at codons 390-393, and premature termination at codon 394. The duplication resulted from an insertion of a cytosine within a wildtype run of 7 cytosines in exon 10. The mutation was predicted to delete the putative zinc finger domain. The patients also had osteopetrosis and died of mycobacterial infection.</Attribute>
              <Citation>
                <ID Source="PubMed">11047757</ID>
              </Citation>
              <XRef DB="OMIM" ID="300291" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Kosaki et al. (2001) described an unusual family in which a girl with this heterozygous mutation had skin abnormalities with streaky hyperpigmented macules, features of ectodermal dysplasia, including decreased sweating, thin hair, and hypodontia, and onset of recurrent infections around 4 years of age. She later developed pulmonary and renovascular hypertension, and died at age 11 years after cardiac catheterization. IgD and IgE were increased. X-inactivation studies of peripheral blood leukocytes showed a random pattern. The mother had hyperpigmented macules in a streaky configuration on the trunk and limbs at several weeks of age, but never developed immunodeficiency; DNA from the mother was not studied. The family had previously been reported by Akiyama et al. (1994) as having 'linear and whorled nevoid hypermelanosis (see 614323). Zonana and Ferguson (2001) noted that the findings of random X inactivation in the girl reported by Kosaki et al. (2001) was unusual, and postulated that other molecular mechanisms may have been at play, including the possibility of skewed X inactivation in different leukocyte subsets. These authors emphasized that this phenotype in females is a very rare occurrence, and that generally, only males are affected.</Attribute>
              <Citation>
                <ID Source="PubMed">11484156</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">8169255</ID>
              </Citation>
              <Citation>
                <CitationText>Zonana, J., Ferguson, B. Reply to Kosaki et al. Am. J. Hum. Genet. 69: 665-666, 2001.</CitationText>
              </Citation>
              <XRef DB="OMIM" ID="614323" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Aradhya et al. (2001) identified the same frameshift mutation, referred to as a 1-bp duplication in the 7-cytosine tract (1161_1162dupC) of the IKBKG gene, in a male patient (family XL344) with EDAID1. Female members of the family, who were heterozygous for the mutation, had typical signs of incontinentia pigmenti (IP; 308300). The affected male exhibited skin pigmentation, dental problems, and immune dysfunction. He suffered multiple episodes of infection, including meningitis and pneumonia, due to poor lymphocyte function and remarkably low levels of circulating IgG. He also exhibited heat intolerance with hyperthermia, anhidrosis, eczema, and fine sparse hair, which led to a diagnosis of ectodermal dysplasia. At the age of 3 years he was receiving routine supplements of IgG to prevent recurrent infections. He showed hepatosplenomegaly and had contracted Mycobacterium avium intracellulare, an infection common among patients with AIDS. Aradhya et al. (2001) identified a different mutation involving the same C(7) tract in another family; see 300248.0012.</Attribute>
              <Citation>
                <ID Source="PubMed">11179023</ID>
              </Citation>
              <XRef DB="OMIM" ID="308300" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="IKBKG" />
          </GeneList>
          <Name>IKBKG, 1-BP DUP, 1167C</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DUP, 1167C</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="300248.0008" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">ECTODERMAL DYSPLASIA AND IMMUNODEFICIENCY 1</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2640603" SubmissionDate="2022-05-27" DateLastUpdated="2024-07-29" DateCreated="2020-06-13">
        <ClinVarSubmissionID localKey="300248.0008_INCONTINENTIA PIGMENTI" title="IKBKG, 1-BP DUP, 1167C_INCONTINENTIA PIGMENTI" />
        <ClinVarAccession Accession="SCV001335503" DateUpdated="2024-07-29" DateCreated="2020-06-13" Type="SCV" Version="4" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2001-09-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to included disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 2 brothers (family 4) with lethal hypohidrotic ectodermal dysplasia with immune deficiency-1 (EDAID1; 300291), Zonana et al. (2000) identified a hemizygous 1-bp duplication (c.1167_1168dupC) in exon 10 of the IKBKG gene, predicted to result in a frameshift, the addition of novel amino acids at codons 390-393, and premature termination at codon 394. The duplication resulted from an insertion of a cytosine within a wildtype run of 7 cytosines in exon 10. The mutation was predicted to delete the putative zinc finger domain. The patients also had osteopetrosis and died of mycobacterial infection.</Attribute>
              <Citation>
                <ID Source="PubMed">11047757</ID>
              </Citation>
              <XRef DB="OMIM" ID="300291" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Kosaki et al. (2001) described an unusual family in which a girl with this heterozygous mutation had skin abnormalities with streaky hyperpigmented macules, features of ectodermal dysplasia, including decreased sweating, thin hair, and hypodontia, and onset of recurrent infections around 4 years of age. She later developed pulmonary and renovascular hypertension, and died at age 11 years after cardiac catheterization. IgD and IgE were increased. X-inactivation studies of peripheral blood leukocytes showed a random pattern. The mother had hyperpigmented macules in a streaky configuration on the trunk and limbs at several weeks of age, but never developed immunodeficiency; DNA from the mother was not studied. The family had previously been reported by Akiyama et al. (1994) as having 'linear and whorled nevoid hypermelanosis (see 614323). Zonana and Ferguson (2001) noted that the findings of random X inactivation in the girl reported by Kosaki et al. (2001) was unusual, and postulated that other molecular mechanisms may have been at play, including the possibility of skewed X inactivation in different leukocyte subsets. These authors emphasized that this phenotype in females is a very rare occurrence, and that generally, only males are affected.</Attribute>
              <Citation>
                <ID Source="PubMed">11484156</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">8169255</ID>
              </Citation>
              <Citation>
                <CitationText>Zonana, J., Ferguson, B. Reply to Kosaki et al. Am. J. Hum. Genet. 69: 665-666, 2001.</CitationText>
              </Citation>
              <XRef DB="OMIM" ID="614323" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Aradhya et al. (2001) identified the same frameshift mutation, referred to as a 1-bp duplication in the 7-cytosine tract (1161_1162dupC) of the IKBKG gene, in a male patient (family XL344) with EDAID1. Female members of the family, who were heterozygous for the mutation, had typical signs of incontinentia pigmenti (IP; 308300). The affected male exhibited skin pigmentation, dental problems, and immune dysfunction. He suffered multiple episodes of infection, including meningitis and pneumonia, due to poor lymphocyte function and remarkably low levels of circulating IgG. He also exhibited heat intolerance with hyperthermia, anhidrosis, eczema, and fine sparse hair, which led to a diagnosis of ectodermal dysplasia. At the age of 3 years he was receiving routine supplements of IgG to prevent recurrent infections. He showed hepatosplenomegaly and had contracted Mycobacterium avium intracellulare, an infection common among patients with AIDS. Aradhya et al. (2001) identified a different mutation involving the same C(7) tract in another family; see 300248.0012.</Attribute>
              <Citation>
                <ID Source="PubMed">11179023</ID>
              </Citation>
              <XRef DB="OMIM" ID="308300" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="IKBKG" />
          </GeneList>
          <Name>IKBKG, 1-BP DUP, 1167C</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DUP, 1167C</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="300248.0008" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="included">INCONTINENTIA PIGMENTI</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4996360" SubmissionDate="2022-07-27" DateLastUpdated="2022-10-01" DateCreated="2022-07-28">
        <ClinVarSubmissionID localKey="NM_003639.3:c.1167dupC|OMIM:308300" submittedAssembly="not applicable" />
        <ClinVarAccession Accession="SCV002553187" DateUpdated="2022-10-01" DateCreated="2022-07-28" Type="SCV" Version="2" SubmitterName="GeneReviews" OrgID="500062" OrganizationCategory="resource" OrgAbbreviation="GeneReviews" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no classification provided</ReviewStatus>
          <GermlineClassification>not provided</GermlineClassification>
          <Citation>
            <ID Source="BookShelf">NBK1472</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18222329</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_003639.3:c.1167dupC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0021171" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11808016</SubmissionName>
          <SubmissionName>SUB11861064</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5462827" SubmissionDate="2022-12-13" DateLastUpdated="2022-12-31" DateCreated="2022-12-31">
        <ClinVarSubmissionID localKey="NM_001099857.5:c.1167dup|OMIM:300291;300636;308300" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002809225" DateUpdated="2022-12-31" DateCreated="2022-12-31" Type="SCV" Version="1" SubmitterName="Fulgent Genetics, Fulgent Genetics" OrgID="500105" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-10-27">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001099857.5:c.1167dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="TraitChoice">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="300291" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="300636" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="308300" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12390657</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7360408" SubmissionDate="2023-07-03" DateLastUpdated="2023-07-08" DateCreated="2023-07-08">
        <ClinVarSubmissionID localKey="SUB13573777" submittedAssembly="GRCh38" title="SUB13573777" />
        <ClinVarAccession Accession="SCV003935199" DateUpdated="2023-07-08" DateCreated="2023-07-08" Type="SCV" Version="1" SubmitterName="Department of Medical Genetics, College of Basic Medicine, Army Medical University" OrgID="506778" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>de novo</Origin>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">30</Age>
              <Age Type="maximum" age_unit="years">39</Age>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>female</Gender>
            </Sample>
            <Method>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001099856.6:c.1371_1372insC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="308300" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13573777</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8994647" SubmissionDate="2024-04-05" DateLastUpdated="2024-04-15" DateCreated="2024-04-15">
        <ClinVarSubmissionID localKey="d3660269-192f-4f8d-9d61-becccad7c04d_1|OMIM:300636" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV004812036" DateUpdated="2024-04-15" DateCreated="2024-04-15" Type="SCV" Version="1" SubmitterName="Undiagnosed Diseases Network, NIH" OrgID="505999" OrganizationCategory="consortium" OrgAbbreviation="UDN" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-05-10">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>maternal</Origin>
              <Tissue>Blood</Tissue>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">0</Age>
              <Age Type="maximum" age_unit="years">9</Age>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>male</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0000698" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0002007" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0002721" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="IKBKG" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>p.(E390Rfs*5)</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_003639.3:c.1167dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="300636" Type="MIM" />
          </Trait>
        </TraitSet>
        <StudyName>Undiagnosed Diseases Network (NIH), UDN</StudyName>
        <SubmissionNameList>
          <SubmissionName>SUB14360540</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4996360" TraitType="Disease" MappingType="XRef" MappingValue="C0021171" MappingRef="MedGen">
        <MedGen CUI="C0021171" Name="Incontinentia pigmenti syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8994647" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000698" MappingRef="HP">
        <MedGen CUI="C0266037" Name="Conical tooth" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2640603" TraitType="Disease" MappingType="Name" MappingValue="INCONTINENTIA PIGMENTI" MappingRef="Alternate">
        <MedGen CUI="C0021171" Name="Incontinentia pigmenti syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5462827" TraitType="Disease" MappingType="XRef" MappingValue="300636" MappingRef="OMIM">
        <MedGen CUI="C1970879" Name="Immunodeficiency 33" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="958041" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5462827" TraitType="Disease" MappingType="XRef" MappingValue="308300" MappingRef="OMIM">
        <MedGen CUI="C0021171" Name="Incontinentia pigmenti syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8994647" TraitType="Finding" MappingType="XRef" MappingValue="HP:0002007" MappingRef="HP">
        <MedGen CUI="C0221354" Name="Frontal bossing" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5462827" TraitType="Disease" MappingType="XRef" MappingValue="300291" MappingRef="OMIM">
        <MedGen CUI="C1846008" Name="Ectodermal dysplasia and immunodeficiency 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8994647" TraitType="Disease" MappingType="XRef" MappingValue="300636" MappingRef="OMIM">
        <MedGen CUI="C1970879" Name="Immunodeficiency 33" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7360408" TraitType="Disease" MappingType="XRef" MappingValue="308300" MappingRef="OMIM">
        <MedGen CUI="C0021171" Name="Incontinentia pigmenti syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="32443" TraitType="Disease" MappingType="Name" MappingValue="ECTODERMAL DYSPLASIA AND IMMUNODEFICIENCY 1" MappingRef="Preferred">
        <MedGen CUI="C1846008" Name="Ectodermal dysplasia and immunodeficiency 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8994647" TraitType="Finding" MappingType="XRef" MappingValue="HP:0002721" MappingRef="HP">
        <MedGen CUI="C0021051" Name="Immunodeficiency" />
      </TraitMapping>
    </TraitMappingList>
    <DeletedSCVList>
      <SCV>
        <Accession Version="4" DateDeleted="2020-06-11">SCV000223087</Accession>
      </SCV>
    </DeletedSCVList>
  </ClassifiedRecord>
</VariationArchive>

